Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treating COVID-19 With Hydroxychloroquine: A Multicenter Randomized, Double-blind, Placebo-controlled Clinical Trial in Hospitalized Adults

NCT04369742 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT04369742
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04369742 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treating COVID-19 With Hydroxychloroquine: A Multicenter Randomized, Double-blind, Placebo-controlled Clinical Trial in Hospitalized Adults
Lead sponsor
NYU Langone Health
Phase
Phase 2
Overall status
Terminated
Start date
April 15, 2020
Completion date
April 1, 2021
Enrollment
128 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19